Navigation Links
Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators
Date:5/31/2012

NATICK, Mass., May 31, 2012 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved revised product labeling for the Boston Scientific Corporation (NYSE: BSX) INCEPTA™, ENERGEN™, PUNCTUA™, COGNIS® and TELIGEN® implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), to reflect increased longevity projections for these devices.  The longevity projections are based on data submitted to the FDA and vary for each device dependent on the model type and settings.

Projected device longevity exceeds 10 years for some models of Boston Scientific ICDs, and approaches eight years for its CRT-D devices, and nearly double that of comparable competitive device models (1,2,3).  The company backs these devices with warranties of up to 10 years* in the U.S. and many other international markets.  Depending on the model, the device warranties are also up to twice as long as other currently-marketed comparable devices."We're pleased with the new labeling for our U.S. defibrillator products which provides doctors and patients with additional assurance about the longevity and reliability of these devices," said Kenneth Stein, M.D., chief medical officer of Boston Scientific's Cardiac Rhythm Management Group.  "Boston Scientific ICDs and CRT-Ds benefit from our proprietary advanced battery technology.  The new battery was first introduced in the COGNIS and TELIGEN devices in 2008 and has now been incorporated into our newest devices with up to a 10-year warranty."

"The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) long-term follow-up study results, which were recently presented at the Heart Rhythm Society annual meeting in Boston, demonstrates that ICD therapy continues to benefit patients for a median follow-up of 11 years.  Particularly in New York H
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... SAN DIEGO, Jan. 22, 2015  ResMed Inc. (NYSE: ... 31, 2014. Revenue for the quarter was $423.0 million, a ... 2013 (a 14 percent increase on a constant currency basis). ... compared to the quarter ended December 31, 2013. Diluted earnings ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015  Profil Institute ... focused on diabetes and obesity, announced today a new ... Drug Development,  published by Springer, a leading global scientific ... extensively analyze and illustrate techniques for use in early ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/w25xpc/allergy ) has announced ... Source, Product & by End User - Global Forecast to ... global allergy diagnostics market is valued at $1,228.58 million in ... 12.67%, to reach $2,230.72 million by 2019. Allergy diagnostics is ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 3
... 2012 Synteract , Inc., a full-service contract ... developing new therapies to combat the growing issue of ... Great Strides fundraising walk to benefit the Cystic ... Rempex (on behalf of Aptalis Pharma) are also working ...
... Ind., May 2, 2012  Hill-Rom Holdings, Inc. (NYSE: ... declared a fiscal year 2012 third quarter dividend of $0.125 ... to shareholders of record as of the close of business ... HOLDINGS, INC. Hill-Rom is a leading worldwide manufacturer ...
Cached Medicine Technology:Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Woodloch Pines, an ... has been selected by TripAdvisor as the number one best ... 6th best in the world for their annual Travelers’ Choice ... travel community . The website is home to millions of ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The Incredible Bulk ... Ben Pakulski to increase lean muscle by up to 30lbs ... caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative ... it is a step-by-step, scientific diet formula that allows the ...
(Date:1/22/2015)... 22, 2015 The federal court overseeing thousands ... District Court, Southern District of West Virginia has upheld a ... proceeding’s first bellwether trial. In an Order dated January 21st, ... after finding that C.R. Bard had not proven a miscarriage ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... at a heightened risk from hypertension as they inhale salt// ... Desert Medicine Research Centre in Jodhpur, India had measured the ... Rajasthan., ,They divided the workers into two groups: those ... involved in crushing, grinding, milling and packing salt and those ...
... the image of a medication. Rather it is the “king ... a respite in the sweltering heat and charms one and ... to fight tumours and make cancer fret. Nutritionally mango is ... ,Now research conducted at Indian Toxicology Research Institute (ITRC), Lucknow ...
... Pricing Authority (NPPA) has been working// on bringing down ... with the manufacturers and has finally succeeded. According to ... to bring about a price reduction ranging between 2.14% ... personal hearing to explain the reasons for steep price ...
... the Medical Oncology of Yale School// of Medicine published ... high levels of TRAIL-R2 causes a decrease in survival ... are cell surface receptors that triggers cell death, the ... with survival, high TRAIL-R2 expression strongly correlated with decreased ...
... the raising temperatures// in the summer months are quite difficult. ... people are heat exhaustion and heat stroke. ,The ... School had given some tips to the elderly people that ... ,In addition to heading for the air conditioning, staying ...
... sweating even during the// cold months of winter may ... Saint Louis University School of Medicine had reported that ... be effective for treating this condition. ,Interim data ... Botox? (botulinum toxin type A) for the treatment of ...
Cached Medicine News:Health News:Inhaling Salt Can Lead To Hypertension 2Health News:New Discovery to Increase Survival of Breast cancer Patients 2Health News:Elderly People Needs To Tackle The Heat Effectively 2Health News:Good News For Those Suffering From Excessive Sweating 2Health News:Good News For Those Suffering From Excessive Sweating 3
... Only Heartlab delivers the performance ... cardiovascular information management systems. As ... and services set the benchmark. ... functionality, high-speed performance and technological ...
... the first digital solution designed specifically for ... and outside cardiology. From the server core ... Agfas combined expertise in both cine film ... to work the way they want, wherever ...
Precision near-field imaging combined with the best handling IVUS catheter....
... The Medison SonoAce ... digital, NT2000 based ultrasound ... workstation that is DICOM ... applications including general imaging, ...
Medicine Products: